Page last updated: 2024-08-24

cilazapril, anhydrous and Hyperlipemia

cilazapril, anhydrous has been researched along with Hyperlipemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kiselevich, A; London, D; Magen, E; Priluk, R; Viskoper, RJ; Volchek, L; Yosefy, C	1
Arakawa, K; Hirata, K; Liu, R; Saku, K; Shiomi, M; Tateishi, K; Zhang, B	1
Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D	1

Reviews

1 review(s) available for cilazapril, anhydrous and Hyperlipemia

Article	Year
ACE-inhibitors and atherosclerosis. European journal of epidemiology, 1992, Volume: 8 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Arteriosclerosis; Captopril; Cilazapril; Disease Models, Animal; Haplorhini; Hyperlipidemias; Lipid Metabolism; Peptidyl-Dipeptidase A; Pyridazines; Rabbits; Rats	1992

Trials

1 trial(s) available for cilazapril, anhydrous and Hyperlipemia

Article	Year
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2 Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Cholesterol, LDL; Cilazapril; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Endothelium, Vascular; Evoked Potentials; Female; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Kidney; Male; Rosiglitazone; Simvastatin; Skin Physiological Phenomena; Sympathetic Nervous System; Thiazolidinediones; Time Factors; Ultrasonography; Vasodilation	2004

Article

Year

Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.

Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2

Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Cholesterol, LDL; Cilazapril; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Endothelium, Vascular; Evoked Potentials; Female; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Kidney; Male; Rosiglitazone; Simvastatin; Skin Physiological Phenomena; Sympathetic Nervous System; Thiazolidinediones; Time Factors; Ultrasonography; Vasodilation

2004

Other Studies

1 other study(ies) available for cilazapril, anhydrous and Hyperlipemia

Article	Year
Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril. Metabolism: clinical and experimental, 1994, Volume: 43, Issue:3 Topics: Animals; Blood Glucose; Cholesterol, Dietary; Cilazapril; Glucose; Glucose Tolerance Test; Hyperlipidemias; Injections, Intravenous; Insulin; Insulin Resistance; Rabbits	1994